cornellbreastcenter.com
ASCO Poster Presentation: ABT-888 (veliparib)+ Carboplatin in Stage IV BRCA-Associated Breast Cancer
In a poster presentation this week at the American Society of Clinical Oncology (ASCO) conference, researchers presented results from a nationwide study assessing a PARP inhibitor in BRCA-associate…